Voyager Therapeutics (VYGR) Cash & Equivalents Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -45.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.55% |
| Dec 31, 2025 | -12.94% |
| Sep 30, 2025 | -22.48% |
| Jun 30, 2025 | -17.53% |
| Mar 31, 2025 | -17.24% |
| Dec 31, 2024 | -15.30% |
| Sep 30, 2024 | 0.31% |
| Jun 30, 2024 | -13.55% |
| Mar 31, 2024 | 6.69% |
| Dec 31, 2023 | -12.99% |
| Sep 30, 2023 | -23.79% |
| Jun 30, 2023 | 19.18% |
| Mar 31, 2023 | 17.54% |
| Dec 31, 2022 | 4.77% |
| Sep 30, 2022 | 5.43% |
| Jun 30, 2022 | -0.65% |
| Mar 31, 2022 | 5.20% |
| Dec 31, 2021 | 35.83% |
| Sep 30, 2021 | 38.30% |
| Jun 30, 2021 | 25.50% |
| Mar 31, 2021 | -5.68% |
| Dec 31, 2020 | 49.07% |
| Sep 30, 2020 | 45.16% |
| Jun 30, 2020 | 29.60% |
| Mar 31, 2020 | 55.90% |
| Dec 31, 2019 | 32.92% |
| Sep 30, 2019 | 9.17% |
| Jun 30, 2019 | 6.02% |
| Mar 31, 2019 | 49.50% |
| Dec 31, 2018 | 14.39% |
| Sep 30, 2018 | -14.12% |
| Jun 30, 2018 | -11.06% |
| Mar 31, 2018 | 6.44% |
| Dec 31, 2017 | 64.87% |
| Sep 30, 2017 | 96.74% |